Showing 1,449 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Injectable & long-acting HIV treatment

No holiday gift for GSK: FDA sends long-acting HIV injectable back to work

Editor's pick
FiercePharma
24 December 2019
Injectable & long-acting HIV treatment

FDA Defers Approval of First Long-Acting HIV Therapy, Surprising Everyone

Editor's pick
HIV and ID Observations
23 December 2019
New & experimental HIV treatments

CytoDyn Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

Editor's pick
CytoDyn press release
18 December 2019
HIV treatment for children & young people

ViiV Healthcare files submissions to the FDA and EMA for the first-ever dispersible formulation of dolutegravir (DTG) for children living with HIV

Editor's pick
ViiV press release
15 December 2019
Access to healthcare

FDA Releases Analysis of HIV Drug Approval Program for Low-Income Countries

Editor's pick
Contagion Live
10 December 2019
Pharmaceutical industry

Gilead delayed safer HIV drug to extend monopoly profits, advocates allege

Editor's pick
San Francisco Chronicle
6 December 2019
Health services & systems

Communities together — accelerating uptake of promising new HIV/AIDS medicines

Editor's pick
Devex
5 December 2019
New & experimental HIV treatments

ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
5 December 2019
PrEP programmes & uptake

Gilead’s converting Truvada PrEP users to Descovy faster than expected: analyst

Editor's pick
FirecePharma
4 December 2019
Pharmaceutical industry

HIV Affects Millions of Women. So Why Isn’t a New PrEP Drug Approved for Their Use?

Editor's pick
Rewire News
3 December 2019
HIV treatment for children & young people

New Strawberry-Flavored H.I.V. Drugs for Babies Are Offered at $1 a Day

Editor's pick
New York Times
30 November 2019
PrEP policies & guidelines

Barring cisgender women from the Descovy trials was a bad call

Editor's pick
STAT
25 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
Pharmaceutical industry

Untangling the Trump administration's lawsuit over an HIV prevention drug

Editor's pick
Science
11 November 2019
Pharmaceutical industry

U.S. sues drugmaker Gilead over patents on HIV prevention treatment

Editor's pick
San Francisco Chronicle
8 November 2019
Bad science & bogus treatments

Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.

Editor's pick
TheBodyPro
7 November 2019
PrEP policies & guidelines

United States Files Patent Infringement Lawsuit Against Gilead Related to Truvada® and Descovy® for Pre-exposure Prophylaxis of HIV

Editor's pick
U.S. Department of Health & Human Services
7 November 2019
PrEP policies & guidelines

Much Ado About Descovy

Editor's pick
TheBody
16 October 2019
Pharmaceutical industry

Gilead's Descovy nabs PrEP nod. Next step: Convert Truvada patients before generics hit

Editor's pick
FiercePharma
4 October 2019
Pharmaceutical industry

AIDS United Signals Change Following Gilead Controversy

Editor's pick
My Fabulous Disease
30 September 2019
New & experimental HIV treatments

European Commission Approves Trogarzo

Editor's pick
Global Newswire
27 September 2019
Activism & civil society

HIV Organizations and Workers Should Routinely Disclose Ties to Pharma Industry

Editor's pick
TheBodyPro
27 September 2019
Side effects

Unsure whether I'll join Gilead lawsuit

Editor's pick
Bay Area Reporter
27 September 2019
Pharmaceutical industry

Gilead Duped Me into Being Their Mouthpiece. Here’s How.

Editor's pick
My Fabulous Disease
25 September 2019